Statement of Use

BLOXIVERZ

EXELA STERILE MEDICINES LLC

Trademark/Service Mark Statement of Use

PTO Form 1553 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 10/31/2017)

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 85686242
LAW OFFICE ASSIGNED LAW OFFICE 111
EXTENSION OF USE NO
MARK SECTION
MARK http://tess2.gov.uspto.report/ImageAgent/ImageAgentProxy?getImage=85686242
LITERAL ELEMENT BLOXIVERZ
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION (current)
NAME Éclat Pharmaceuticals, LLC
STREET Suite A
CITY Chesterfield
STATE Missouri
ZIP/POSTAL CODE 63005
COUNTRY United States
OWNER SECTION (proposed)
NAME Éclat Pharmaceuticals, LLC
STREET 699 Trade Center Boulevard, Suite A
CITY Chesterfield
STATE Missouri
ZIP/POSTAL CODE 63005
COUNTRY United States
CORRESPONDENCE SECTION (current)
NAME Sofia Jeong
FIRM NAME Troutman Sanders LLP
STREET 600 Peachtree St. NE, Suite 5200
CITY Atlanta
STATE Georgia
POSTAL CODE 30308
COUNTRY United States
PHONE 404.885.3678
FAX 404.962.6596
EMAIL Trademarks@TroutmanSanders.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER 244174.2
CORRESPONDENCE SECTION (proposed)
NAME Sofia Jeong
FIRM NAME Troutman Sanders LLP
STREET 600 Peachtree Street NE, Suite 5200
CITY Atlanta
STATE Georgia
POSTAL CODE 30308
COUNTRY United States
PHONE 404.885.3678
FAX 404.965.6596
EMAIL Trademarks@TroutmanSanders.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER 244174.000002
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Injectable medication used to reverse anesthesia
GOODS OR SERVICES KEEP ALL LISTED
FIRST USE ANYWHERE DATE 07/26/2013
FIRST USE IN COMMERCE DATE 07/26/2013
SPECIMEN FILE NAME(S) \\TICRS\EXPORT16\IMAGEOUT 16\856\862\85686242\xml11 \SOU0002.JPG
        \\TICRS\EXPORT16\IMAGEOUT 16\856\862\85686242\xml11 \SOU0003.JPG
SPECIMEN DESCRIPTION photo of good showing the Mark
REQUEST TO DIVIDE NO
PAYMENT SECTION
NUMBER OF CLASSES IN USE 1
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 100
TOTAL AMOUNT 100
SIGNATURE SECTION
SIGNATORY FILE NAME(S) \\TICRS\EXPORT16\IMAGEOUT 16\856\862\85686242\xml11 \SOU0004.JPG
SIGNATORY'S NAME Rich Greene
SIGNATORY'S POSITION Director, Corporate Account & National Sales
FILING INFORMATION
SUBMIT DATE Wed Aug 07 12:40:05 EDT 2013
TEAS STAMP USPTO/SOU-XX.XXX.XXX.X-20
130807124005552356-856862
42-50030f428759874dbee153
22f10dc849aa8f94d5d523f18
3e5675d6b7a6e4c035-CC-999
9-20130807123748880698



PTO Form 1553 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 10/31/2017)


Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:
MARK: BLOXIVERZ(Standard Characters, see http://tess2.gov.uspto.report/ImageAgent/ImageAgentProxy?getImage=85686242)
SERIAL NUMBER: 85686242



The applicant, Éclat Pharmaceuticals, LLC, having an address of
      699 Trade Center Boulevard, Suite A
      Chesterfield, Missouri 63005
      United States
is submitting the following allegation of use information:

For International Class 005:
Current identification: Injectable medication used to reverse anesthesia

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 07/26/2013, and first used in commerce at least as early as 07/26/2013, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) photo of good showing the Mark.
Specimen File1
Specimen File2


The applicant is not filing a Request to Divide with this Allegation of Use form. The applicant's current Correspondence Information: Sofia Jeong of  Troutman Sanders LLP
      600 Peachtree St. NE, Suite 5200
      Atlanta, Georgia (GA) 30308
      United States (USX)
The docket/reference number is 244174.2.
The applicant's proposed Correspondence Information: Sofia Jeong of  Troutman Sanders LLP
      600 Peachtree Street NE, Suite 5200
      Atlanta, Georgia (GA) 30308
      United States (USX)
The docket/reference number is 244174.000002.

The phone number is 404.885.3678.

The fax number is 404.965.6596.

The email address is Trademarks@TroutmanSanders.com.

A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.


Declaration



Signature

Signatory's Name: Rich Greene
Signatory's Position: Director, Corporate Account & National Sales

RAM Sale Number: 85686242
RAM Accounting Date: 08/07/2013

Serial Number: 85686242
Internet Transmission Date: Wed Aug 07 12:40:05 EDT 2013
TEAS Stamp: USPTO/SOU-XX.XXX.XXX.X-20130807124005552
356-85686242-50030f428759874dbee15322f10
dc849aa8f94d5d523f183e5675d6b7a6e4c035-C
C-9999-20130807123748880698



Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed